Amundi Asset Management US’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-637
Closed -$45K 1653
2018
Q3
$45K Hold
637
﹤0.01% 1523
2018
Q2
$47K Buy
+637
New +$47K ﹤0.01% 1517